Diagnostic Catheterization and Coronary Therapeutics

Improving Treatment to Improve Lives

The Minneapolis Heart Institute Foundation® (MHIF) has built its reputation as one of the nation’s most respected and distinguished leaders in coronary artery disease research and treatment. This national recognition in coronary therapeutics comes, in part, from MHIF’s pioneering work in the treatment of heart attacks. In 2003, MHIF investigators along with Minneapolis Heart Institute® at Abbott Northwestern Hospital developed a program, called Level One, which focuses on rapid transfer and treatment of heart attack patients who present to hospitals without advanced cardiovascular capabilities. The Level One Program has proven that rural patients, when appropriately treated, can expect the same level of care and outcomes as those who present to major medical centers. It has become the model for care of heart attack victims across the nation.

Other research highlights include helping to develop drug-eluting stents that have revolutionized coronary care, and perfecting new products and techniques for chronic total occlusions, completely blocked arteries that previously could not be treated without bypass surgery. The Minneapolis Heart Institute Foundation continues to evaluate new treatment delivery models such as Tele-Health, which provides cardiology consultation from Minneapolis Heart Institute® physicians for rural clinics. Research from MHIF is a critical component to best in class treatment, and a key contributor to advancing the treatment of coronary artery disease worldwide.

Commitment to Advancing Therapies That Improve Outcomes

Chronic total occlusions (CTOs) occur when the coronary artery is completely obstructed for more than three months. CTOs are very common, affecting between 15 and 50 percent of patients undergoing coronary angiography. Percutaneous coronary intervention (PCI) of chronic total occlusions (CTOs) is increasingly being performed in patients with advanced coronary artery disease. This type of intervention requires skilled physicians who have expertise in opening CTOs. The Minneapolis Heart Institute® at Abbott Northwestern Hospital has established its CTO and complex PCI Center to best serve this population of patients. Manos Brilakis, MD leads this center to provide world class care and drive continued research to further improve outcomes for patients.

Current Studies

BIOFLOW-V